Deferasirox

Drug Details

Deferasirox is a medication designed to manage excess iron in the body, primarily due to frequent blood transfusions or specific blood disorders like non-transfusion-dependent thalassemia. It is suitable for patients aged 2 and older who receive regular transfusions, as well as those aged 10 and older with the genetic condition, NTDT, even if they do not require transfusions. This drug belongs to a group of medications called iron-chelating agents. It functions by binding to excess iron, facilitating its removal through stool. Available in various forms such as tablets (Jadenu), dissolvable tablets (Exjade), and granules (Jadenu Sprinkle), Deferasirox is typically taken daily over a prolonged period to effectively reduce iron levels, which can take several months. By reducing iron accumulation, this medication helps lower the risk of serious health issues like heart failure, liver disease, and diabetes. Common side effects include stomach pain, nausea, and diarrhea. Always consult healthcare professionals before starting any medication to ensure it is safe and appropriate for your condition.